Article Details
Retrieved on: 2024-10-01 19:36:55
Tags for this article:
Click the tags to see associated articles and topics
Summary
Evercore ISI's analyst raised Danaher's price target, citing positive MedTech utilization and a healthy capex outlook. The piece highlights bioprocess and instrument trends in life science tools, reflecting on Danaher's MedTech market performance. Tags: 'Danaher, Evercore, DHR'.
Article found on: www.tipranks.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here